Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Kezar Life Sciences Cash from Operations (Annual) : -51.78M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -51.78M |
| December 31, 2024 | -74.21M |
| December 31, 2023 | -81.64M |
| December 31, 2022 | -58.85M |
| December 31, 2021 | -42.44M |
| Date | Value |
|---|---|
| December 31, 2020 | -36.95M |
| December 31, 2019 | -29.88M |
| December 31, 2018 | -20.79M |
| December 31, 2017 | -8.109M |
| December 31, 2016 | -9.76M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| NovelStem International Corp. | -0.1676M |
| Brainstorm Cell Therapeutics, Inc. | -6.975M |
| Summit Therapeutics, Inc. | -322.93M |
| Protara Therapeutics, Inc. | -56.36M |
| Clene, Inc. | -18.55M |